跳至主要内容
MedPath Trial logoMedPath TrialMedPath Trial Home
临床试验/CTRI/2024/12/078710
CTRI/2024/12/078710招募中4 期

Evaluation of the Efficacy of single modified Y-shaped Titanium miniplate in the management of Mandibular Angle fractures.

未提供1 个研究点 分布在 1 个国家目标入组 25 人开始时间: 2025年1月8日最近更新:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

试验速览

阶段
4 期
状态
招募中
入组人数
25
试验地点
1
主要终点
Intra operative time
研究概览研究设计入排标准结局指标研究者研究点记录与标识符相似试验

研究概览

简要总结

The present study is undertaken to evaluate the clinical outcomes associated with the use of modified Y shaped titanium miniplate placed at the angle of mandible. Modified Y shaped titanium plate offers advantage because of its unique design which is designed by us. As it reinforces the stability of the mandibular fractures by  modification of straight 4 hole titanium mini plate with  angulated 2 hole accessory arm.

研究设计

研究类型
Interventional
分配方式
Na
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 60.00 Year(s)（—）
性别
All

入选标准

  • •1.patients aged more than 18 years 2.patients with mandibular angular fractures.

排除标准

  • •patients who are having high risk systemic illness.

结局指标

主要结局

Intra operative time

时间窗: 24 weeks

Stability of fixation

时间窗: 24 weeks

Biting Efficiency

时间窗: 24 weeks

次要结局

  • Pain in the Surgical site(Mouth opening)

研究者

发起方
未提供
责任方
Principal Investigator
主要研究者

Dr Gudipalli Sudhakar

Government Dental College and Hospital Vijayawada

研究点 (1)

Loading locations...

相似试验

招募中
不适用
Efficacy of yogottama gutika and gokshura taila Matra vasti in the management of Kati graha -Inter Vertebral Disc Prolapse
CTRI/2024/10/075852Dr Baliga Ashok Kumar40
已完成
2 期
A Study to Evaluate the Safety, Efficacy of SYH2053 in Chinese Participants With Non-familial Hypercholesterolemia and Mixed Hyperlipidemia
NCT07421232CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.156
尚未招募
不适用
To compare the effect of Shirodhara with Takra and Jatamansi oil in two group of 15 patients in the management of Anidra w.s.r Primary Insomnia
CTRI/2024/06/068545Dr Amrita Kumari30
招募中
3 期
A Study to Evaluate the Safety, Efficacy of SYH2053 as Monotherapy in Chinese Participants With Non-familial Hypercholesterolemia or Mixed Hyperlipidemia
NCT07421297CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.760
尚未招募
3 期
A Study to Evaluate the Safety, Efficacy of SYH2053 in Chinese Participants With Non-familial Hypercholesterolemia and Mixed Hyperlipidemia on a Background of Lipid-lowering Therapy
NCT07421284CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.900